Nipro Corporation (FRA:5FA)

Market Cap	1.34B -2.0%
Revenue (ttm)	3.55B +4.1%
Net Income	82.59M +199.6%
EPS	0.45 +199.6%
Shares Out	n/a
PE Ratio	16.24
Forward PE	n/a
Dividend	0.15 (1.85%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	n/a
Open	8.05
Previous Close	8.05
Day's Range	8.05 - 8.05
52-Week Range	7.30 - 8.95
Beta	n/a
RSI	37.14
Earnings Date	May 12, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1947
• Employees: 39,168
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5FA

Financial Performance

In fiscal year 2025, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.

Financial numbers in JPY